OUR PRODUCTS

MOBILE APPS

GENERAL INFO

OGN

Stock ticker: NYSE

PRICE

CHANGE

CAPITALIZATION

Organon & Co (OGN) Ownership - Who owns Organon & Co?

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

30 Hudson Street

Phone

+1 551 430-6900

Employees

10000

Web

https://www.organon.com

Details

Group

Domestic Stock Funds

Fundamentals

OGN

Capitalization

2.39B

P/E Ratio

3.42

Risk (Beta)

0.77

Dividend Yield

0.07

Total Cash

599M

Total Cash/Share

2.30

Total Debt

8.9B

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

24.14%

Revenue

6.28B

ROE

N/A

Book Value

733M

P/B Ratio

3.26

Cash Flow

N/A

Earnings

2.72

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

1.65

Current Revenue Per Employee

159400.00

Dividends Per Share - Security

0.02

EBITDA

1.5B

Float

N/A

Float - Current

N/A

Gross Income Margin

54.83

Revenue To Assets

5.46

Shares Held By Institutions

3.66B

Shares Outstanding - Current

260M

Total Liabilities

12.8B

Total Volume MTD

N/A

Value

Gain YTD

-37.061

View a ticker or compare two or three

Compare

OGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For OGN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. OGN showed earnings on August 05, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsMajor